Design Therapeutics Inc (DSGN)
4.68
-0.40
(-7.78%)
USD |
NASDAQ |
Jan 10, 12:33
Design Therapeutics SG&A Expense (Quarterly): 4.37M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp | 0.946M |
| Traws Pharma Inc | 3.48M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |
| iBio Inc | 2.801M |